380,218 Shares in Sotera Health Company $SHC Bought by Nuveen LLC

Key Points

• Nuveen LLC has invested approximately $4.43 million in Sotera Health by acquiring 380,218 shares, representing about 0.13% of the company.
• Other hedge funds, including Invesco Ltd. and Deutsche Bank AG, have also raised their stakes significantly in Sotera Health during the first quarter.
• Analysts have upgraded Sotera Health's stock rating, with Goldman Sachs increasing its target price from $14.00 to $17.00, indicating a generally positive outlook on the company's performance.

Nuveen LLC purchased a new stake in Sotera Health Company (NASDAQ:SHC - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 380,218 shares of the company's stock, valued at approximately $4,433,000. Nuveen LLC owned 0.13% of Sotera Health at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Sculptor Capital LP acquired a new stake in shares of Sotera Health during the 4th quarter worth about $68,400,000. Two Seas Capital LP increased its position in Sotera Health by 624.0% in the 4th quarter. Two Seas Capital LP now owns 2,896,136 shares of the company's stock valued at $39,619,000 after acquiring an additional 2,496,136 shares in the last quarter. D. E. Shaw & Co. Inc. increased its position in Sotera Health by 140.8% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,624,750 shares of the company's stock valued at $35,907,000 after acquiring an additional 1,534,666 shares in the last quarter. Ananym Capital Management LP acquired a new stake in Sotera Health in the 4th quarter valued at about $13,680,000. Finally, Dimensional Fund Advisors LP increased its position in Sotera Health by 27.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,143,955 shares of the company's stock valued at $43,004,000 after acquiring an additional 673,979 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on SHC shares. Wall Street Zen raised shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. The Goldman Sachs Group raised shares of Sotera Health from a "neutral" rating to a "buy" rating and raised their target price for the company from $14.00 to $17.00 in a research note on Monday, May 5th. Finally, Barclays reaffirmed an "overweight" rating on shares of Sotera Health in a research note on Friday, August 8th. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $16.00.

Insider Activity

In other news, insider Michael P. Rutz sold 126,611 shares of Sotera Health stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $16.38, for a total value of $2,073,888.18. Following the sale, the insider directly owned 450,204 shares in the company, valued at $7,374,341.52. This trade represents a 21.95% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 47.55% of the stock is owned by company insiders.

Sotera Health Stock Up 1.0%

SHC traded up $0.17 during trading on Friday, reaching $16.37. The company had a trading volume of 1,031,549 shares, compared to its average volume of 1,765,369. The company has a debt-to-equity ratio of 4.49, a current ratio of 2.47 and a quick ratio of 2.23. Sotera Health Company has a 12 month low of $9.53 and a 12 month high of $17.08. The business's fifty day moving average price is $12.77 and its 200 day moving average price is $12.25. The company has a market cap of $4.65 billion, a P/E ratio of 25.71 and a beta of 1.81.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its quarterly earnings results on Friday, August 8th. The company reported $0.20 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. The firm had revenue of $294.34 million for the quarter, compared to analyst estimates of $275.81 million. During the same quarter in the previous year, the firm posted $0.19 earnings per share. The business's revenue was up 6.4% on a year-over-year basis. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Equities analysts anticipate that Sotera Health Company will post 0.61 EPS for the current year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.